TipRanks on MSN
Pfizer Clinches $10 Billion Metsera Deal as Novo Nordisk Loses Weight-Loss Drug Battle
Pfizer ($PFE) has reached a deal to buy Metsera ($MTSR), a weight-loss drug startup, in a transaction that could total more ...
The companies announced a huge deal that will have implications for investors. Eli Lilly ( LLY 1.39%) and Novo Nordisk ( NVO ...
For long-term investors, there are plenty of reasons to buy and hold Eli Lilly for not only years but decades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback